Feasibility of a Chronic, Minimally Invasive Endovascular Neural Interface

Nicholas L Opie; Gil S Rind; Sam E John; Stephen M Ronayne; David B Grayden; Anthony N Burkitt; Clive N May; Terence J O'Brien; Thomas J Oxley

Conference Proceedings

Feasibility of a Chronic, Minimally Invasive Endovascular Neural Interface

Nicholas L Opie, Gil S Rind, Sam E John, Stephen M Ronayne, David B Grayden, Anthony N Burkitt, Clive N May, Terence J O'Brien, Thomas J Oxley, J Patton, R Barbieri, J Ji, E Jabbari, S Dokos, R Mukkamala, D Guiraud, E Jovanov, Y Dhaher, D Panescu, M Vangils Show all

2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) | IEEE | Published : 2016

University of Melbourne Researchers

Nicholas Opie Author Medicine - Royal Melbourne Hospital

Thomas Oxley Author Medicine - Royal Melbourne Hospital

Sam John Author Biomedical Engineering

Clive May Author Pharmacology and Therapeutics

Stephen Ronayne Author Medicine - Royal Melbourne Hospital

Related Projects (5)

Minimally Invasive Brain Controlled Communication And Navigation

Control Of Prosthetic Limbs From Decoded Brain Signals

This research will restore mobility to patients who suffer from paralysis. We aim to create a device, known as a brain-machine interface, wh..

Ian Potter Foundation Travel Grant

Minimally Invasive Endovascular Neural Stimulation

Neural deficits such as Parkinson’s disease can be helped by electrically stimulating the brain to activate neurons. Current implants requir..

Targeting Therapeutic Stimulation Using Minimally Invasive Neuromodulation

Grants

Awarded by US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office

Awarded by office of Naval Research (ONR)

Awarded by National Health and Medical Research Council of Australia (NHMRC)

Funding Acknowledgements

This research was supported by the US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office contract N66001-12-1-4045; office of Naval Research (ONR) Global N62909-14-1-N020; National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1062532 and Development Grant APP1075117.